Condensed Consolidated Statements of Stockholders’ Equity (Unaudited) - USD ($)	Preferred Stock	Common Stock	Additional Paid-in Capital	Accumulated Equity	Total
Balance at Dec. 31, 2019	$ 14	$ 206,569	$ 85,907,523	$ (89,036,271)	$ (2,922,165)
Balance (in Shares) at Dec. 31, 2019	13,602	206,569,062
Common stock issued on exercise of stock options and warrants		$ 25	1,725		1,750
Common stock issued on exercise of stock options and warrants (in Shares)		25,000
Stock-based compensation expense			439,956		439,956
Sale of common stock		$ 3,710	1,109,290		1,113,000
Sale of common stock (in Shares)		3,710,000
Net loss for the quarter ended				(1,265,091)	(1,265,091)
Balance at Mar. 31, 2020	$ 14	$ 210,304	87,458,494	(90,301,362)	(2,632,550)
Balance (in Shares) at Mar. 31, 2020	13,602	210,304,062
Common stock issued on exercise of stock options and warrants		$ 1,050	72,450		73,500
Common stock issued on exercise of stock options and warrants (in Shares)		1,050,000
Stock-based compensation expense			344.43		344,430
RSA-based non-cash compensation		$ 19	6,508		6,527
RSA-based non-cash compensation (in Shares)		18,750
Cancelation of common stock		$ (1,000)	1,000
Cancelation of common stock (in Shares)		(1,000,000)
Sale of common stock		$ 1,770	529,330		531,100
Sale of common stock (in Shares)		1,770,334
Net loss for the quarter ended				(1,374,709)	(1,374,709)
Balance at Jun. 30, 2020	$ 14	$ 212,143	88,412,212	(91,676,071)	(3,051,702)
Balance (in Shares) at Jun. 30, 2020	13,602	212,143,146
Stock-based compensation expense			344,033		344,033
RSA-based non-cash compensation			3,299		3,299
Recognize beneficial conversion feature			708,034		708,034
Accrual of payment in anticipation of settlement			(1,500,000)		(1,500,000)
Purchase and cancellation of common stock		$ (5,000)	(295,000)		(300,000)
Purchase and cancellation of common stock (in Shares)		(5,000,000)
Net loss for the quarter ended				(1,503,255)	(1,503,255)
Balance at Sep. 30, 2020	$ 14	$ 207,143	87,672,578	(93,179,326)	(5,299,591)
Balance (in Shares) at Sep. 30, 2020	13,602	207,143,146
Balance at Dec. 31, 2020	$ 14	$ 190,529	93,778,591	(92,266,764)	1,702,370
Balance (in Shares) at Dec. 31, 2020	13,602	190,529,320
RSU restricted Stock		$ 31	4,519		4,550
RSU restricted Stock (in Shares)		31,250
Stock-based compensation			170,029		170,029
Common stock issued on exercise of stock options and warrants		$ 1,606	40,394		42,000
Common stock issued on exercise of stock options and warrants (in Shares)		1,605,682
Stock-based compensation expense		$ 158	47,340		47,499
Stock-based compensation expense (in Shares)		158,329
Sale of common stock		$ 7,056	2,250,944		2,258,000
Sale of common stock (in Shares)		7,056,250
Net loss for the quarter ended				(1,086,438)	(1,086,438)
Balance at Mar. 31, 2021	$ 14	$ 199,381	96,291,817	(93,353,202)	3,138,010
Balance (in Shares) at Mar. 31, 2021	13,602	199,380,831
Stock-based compensation			318,818		318,818
Common stock issued on exercise of stock options and warrants		$ 710	28,290		29,000
Common stock issued on exercise of stock options and warrants (in Shares)		709,751
Net loss for the quarter ended				(1,225,360)	(1,225,360)
Net loss for the quarter ended (in Shares)
Balance at Jun. 30, 2021	$ 14	$ 200,090	96,638,926	(94,578,562)	2,260,468
Balance (in Shares) at Jun. 30, 2021	13,602	200,090,582
Stock-based compensation			354,880		354,880
Common stock issued on cashless exercise of options and warrant		$ 957	(957)
Common stock issued on cashless exercise of options and warrant (in Shares)		957,143
Common stock issued on exercise of stock options and warrants		$ 600	36,400		37,000
Common stock issued on exercise of stock options and warrants (in Shares)		600,000
Sale of common stock		$ 4,054	3,036,946		3,041,000
Sale of common stock (in Shares)		4,054,665
Net loss for the quarter ended				(1,451,810)	(1,451,810)
Balance at Sep. 30, 2021	$ 14	$ 205,701	$ 100,066,194	$ (96,030,372)	$ 4,241,539
Balance (in Shares) at Sep. 30, 2021	13,602	205,702,380